We present an effective multi-fidelity framework for shape optimization of super-cavitating hydrofoils using viscous solvers. We employ state-of-the-art machine learning tools such as multi-fidelity ...Gaussian process regression and Bayesian optimization to synthesize data obtained from multi-resolution simulations, and efficiently identify optimal configurations in the design space. We validate our simulation results against experimental data, and showcase the efficiency of the proposed work-flow in a realistic design problem involving the shape optimization of a three-dimensional super-cavitating hydrofoil parametrized by 17 design variables.
We present a CFD characterization of a new type of super-cavitating hydrofoil section designed to have optimal performance both in super-cavitating conditions and in sub-cavitating conditions ...(including transitional regime). The basic concepts of the new profile family are first introduced. Lift, drag and cavity shapes at different cavitation numbers are calculated for a new foil and compared with those of conventional sub-cavitating and super-cavitating profiles. Numerical calculations confirm the superior characteristics of the new hydrofoil family, which is able to attain high lift and efficiency both in sub-cavitating and super-cavitating conditions. Numerical calculations are based on a multi-phase fully turbulent URANSE solver with a bubble dynamic cavitation model to follow the generation and evaporation of the vapor phase. The new profile family, initially devised for ultra-high speed hydrofoil crafts, may result useful for diverse applications such as super-cavitating or surface-piercing propellers or high-speed sailing boats.
We sought to evaluate the efficacy of recombinant human antithrombin III for restoration of heparin responsiveness in heparin-resistant patients scheduled for cardiac surgery.
This was a multicenter, ...randomized, double-blind, placebo-controlled study in heparin-resistant patients undergoing elective cardiac surgery. Patients were considered heparin resistant if the activated clotting time was less than 480 seconds after 400 U/kg heparin. Fifty-two heparin-resistant patients were randomized into 2 cohorts. One cohort received a single bolus (75 U/kg) of recombinant human antithrombin III (n = 28), and the other, the placebo group (n = 24), received a normal saline bolus. If the activated clotting time remained less than 480 seconds, this was defined as treatment failure, and 2 units of fresh frozen plasma were transfused. Patients were monitored for adverse events during hospitalization.
Six (21%) of the patients in the recombinant human antithrombin III group received fresh frozen plasma transfusions compared with 22 (92%) of the placebo-treated patients (
P < .001). Two units of fresh frozen plasma did not restore heparin responsiveness. There was no increased incidence of adverse events associated with recombinant human antithrombin III administration. Postoperative 24-hour chest tube bleeding was not different in the 2 groups. Surrogate measures of hemostatic activation suggested that there was less activation of the hemostatic system during cardiopulmonary bypass in the recombinant human antithrombin III group.
Treatment with recombinant human antithrombin III in a dose of 75 U/kg is effective in restoring heparin responsiveness and promoting therapeutic anticoagulation for cardiopulmonary bypass in the majority of heparin-resistant patients. Two units of fresh frozen plasma were insufficient to restore heparin responsiveness. There was no apparent increase in bleeding associated with recombinant human antithrombin III.
Rasmussen syndrome (RS) is a chronic encephalopathy with uncertain etiology and immune-mediated pathogenesis. The only definitive treatment is represented by functional hemispherectomy. We describe ...the case of a 6.5-year-old female patient who developed several episodes of focal, unilateral clonic seizures. Following laboratory and instrumental investigations, the patient was diagnosed as having RS. A treatment with corticosteroids, intravenous immunoglobulin, and the antiseizure medication (carbamazepine and levetiracetam) did not completely control the seizures. Therefore, the patient was treated with mycophenolate mofetil (MMF), showing a good clinical response, with reduction of the seizures, and stability of the radiological findings. This case suggests the potential utility of MMF in the immune approach to RS.
•Rasmussen encephalitis (RE) is an immune-mediated disease of unknown etiology.•Current definitive treatment for RE is represented by hemispherectomy.•The immune approach of RE has been performed with several agents.•In this case, mycophenolate mofetil was successfully used in a patient with RE.
Vegetation reconstruction based on pollen from coprolites of extinct spotted hyena (
Crocuta crocuta spelaea, Goldfuss 1832) recovered from excavations carried out in 1998 at San Teodoro Cave ...(Sicily, Italy) supports previous indications of pre-Late Glacial conditions. Eight of the twelve coprolites analysed contained well-preserved pollen grains. There is a general similarity between the pollen contents from the coprolites but they show variability. They suggest a main vegetation type dominated by steppic taxa (Poaceae,
Artemisia,
Ephedra, Chenopodiaceae and Asteraceae) but also including arboreal taxa (
Pinus and Cupressaceae). Low percentages of pollen of mesophilous woody taxa (
Quercus,
Betula,
Abies,
Alnus,
Pistacia, among others) are noticeable, suggesting the existence of nearby refugia for temperate and Mediterranean vegetation. A reconstruction of the landscape, using the coprolite pollen record and other pollen records from Sicily and south Italy, shows the predominance, during the pre-Late Glacial, of a wooded steppe biome, with elements representing a variety of local environmental conditions.
There is evidence that spontaneous blinking correlates with cognitive functions. This arises from the observation that blinking rate (BR) is modulated by arousal levels, basic cognitive processes ...(e.g., attention, information processing, memory, etc.) and more complex cognitive functions (e.g., reading, speaking, etc.). The aim of this work was to test the role of BR evaluation in the assessment of cognitive network functioning in awake patients with consciousness deficits.
Thirteen patients were recruited for the study, and were assessed by the Glasgow coma scale (GCS) and Glasgow outcome scale (GOS) on admittance and discharge, respectively. A level of cognitive functioning scale (LCFS) score was assigned at every change in awareness or at least every 2 weeks. At the same time as the clinical tests, the BR was observed for a 5-min period. Ten healthy subjects, observed throughout three non-consecutive days, formed the control group. The BR underwent a different temporal behaviour in the two diagnostic categories. In the persistent vegetative state (PVS) group it remained stable throughout time and linked with the clinical conditions of the patients; whereas in the non-persistent vegetative state (NPVS) group it decreased over time as the cognitive conditions improved. Moreover, a strong inverse correlation was found between overall BR values and LCFS scores. We have concluded that the blinking behaviour changes manifested in PVS and NPVS patients reflect different evolution phases of a cholinergic–dopaminergic imbalance, and that a reduced BR characterizes the early stages of consciousness recovery.